PATH | VRL
Menu

Burden of Paediatric Rotavirus Gastroenteritis (RVGE) and Potential Benefits of a Universal Rotavirus Vaccination Programme with a Pentavalent Vaccine in Spain

This study, published in BMC Public Health, assesses the health outcomes and the economic impact of a universal rotavirus vaccination program with RotaTeq, a pentavalent rotavirus vaccine, against a no vaccination program in Spain. The study concludes that a rotavirus vaccination program with RotaTeq would reduce significantly the significant medical and economic burden of rotavirus gastroenteritis in Spain.

Author: Diez-Domingo J, Surinach NL, Alcalde NM, Betegon L, Largeron N, Trichard M

Published: 2010

» Visit web page (English)

(Located at www.biomedcentral.com)

Citation: Diez-Domingo J, Surinach NL, Alcalde NM, Betegon L, Largeron N, Trichard M. Burden of Paediatric Rotavirus Gastroenteritis (RVGE) and Potential Benefits of a Universal Rotavirus Vaccination Programme with a Pentavalent Vaccine in Spain. BMC Public Health. 2010;10:469.

Resource types: Peer-reviewed journal

Diseases/vaccines: Rotavirus

Topics: Disease burden and surveillance, Disease/vaccine specific information

Regions: North America and Europe